The world’s attention has shifted once again. The conflict in the Middle East now dominates the headlines, and the scale of human suffering there rightly commands global concern. But as the news cycle ...
Based on physico-chemical studies of water-salt systems formed by ammonium and potassium nitrates and sulfates, the formulation of a new fertilizer has been developed by the staff of the Laboratory of ...
Beyond the seas where I have lost a sceptre, I hear the neighing of my dappled nouns, soft participles coming down the steps, treading on leaves, trailing their rustling gowns. Had I more time tonight ...
The Museum of Modern Art presents Woven Histories: Textiles and Modern Abstraction, an in-depth exhibition that delves into the dynamic intersections between weaving and abstraction. Experimentation ...
In this Denatured episode, Jennifer C. Smith-Parker speaks to Indu Navar, CEO and founder of EverythingALS and Dr. Olga Uspenskaya, chief medical officer at VectorY Therapeutics. We’ll discuss patient ...
The U.S. Congress greenlit a historic $315 million in federal ALS research funding for 2026 amid Rare Disease Month, spotlighting biotech progress like VectorY Therapeutics’ first patient dosing in ...